I'd like to know what the company thinks but to date zip.
Wouldn't we all @chrisnj ? lol
........ another week month of absolutely nothing coming out of Starpharma HQ by the looks given the last Starpharma issued ASX announcement was the HY report on 28th Feb 2024 .... wasn't the last 'actual' Viraleze distribution deal back in October 2022 in Hong Kong when @thrasher claimed that Viraleze would 'creep' into mainland China and sales would go through the roof ?
Nothing seems to have surfaced in relation to a distribution deal in Malaysia either despite all the hype on here when the approval was announced almost 12 months ago ? With all these 'discussions' hyped by the previous CEO, you would think Cheryl would be able to finalise these Viraleze distribution deals that have been in negotiations for years in some cases and don't even get me started on all the supposed DEP License deal discussions that have been going on for years with multiple phase 2 results now released ?
- Forums
- ASX - By Stock
- SPL
- Interim decision to amend the Poison Standard for astodrimer sodium
Interim decision to amend the Poison Standard for astodrimer sodium, page-28
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.76M |
Open | High | Low | Value | Volume |
9.4¢ | 9.4¢ | 9.4¢ | $481 | 5.115K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 249999 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 249999 | 0.093 |
1 | 10900 | 0.090 |
1 | 127200 | 0.087 |
1 | 6395 | 0.086 |
3 | 86000 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 65000 | 1 |
0.099 | 49985 | 2 |
0.100 | 111205 | 3 |
0.105 | 66531 | 4 |
0.110 | 13099 | 5 |
Last trade - 11.47am 09/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |